INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 19 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 13 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 13 | +30.0% | 0.00% | – |
| Q4 2017 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 10 | -97.5% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 406 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 406 | -42.5% | 0.00% | – |
| Q4 2016 | $2,000 | – | 706 | +11666.7% | 0.00% | – |
| Q3 2016 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 6 | -60.0% | 0.00% | – |
| Q4 2014 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q2 2014 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q1 2014 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q4 2013 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q3 2013 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atria Investments, Inc | 67,727 | $106,000 | 0.01% |
| Argent Trust Co | 15,121 | $23,000 | 0.01% |
| Acrospire Investment Management LLC | 3,700 | $6,000 | 0.00% |
| IFP Advisors, Inc | 13 | $0 | 0.00% |
| Advisor Group, Inc. | 5,255 | $7,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,756 | $21,000 | 0.00% |
| Citadel Advisors | 14,492 | $22,000 | 0.00% |
| Parallax Volatility Advisers, L.P. | 50,000 | $78,000 | 0.00% |
| Cutler Group LLC / CA | 3,700 | $5,000 | 0.00% |
| MORGAN STANLEY | 59,400 | $92,000 | 0.00% |